Conference Description
The RNA Nanotechnology GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
This year’s program is designed for our broadest audience yet, spanning foundational through translational RNA science and highlighting how RNA structure, folding, and dynamics—revealed by cryo-EM, single-molecule and live-cell imaging, and AI-driven analysis of large-scale datasets—enable new strategies to control RNA function. Scientific sessions will feature advances in RNA therapeutics (including mRNA boosting approaches, small-molecule targeting of RNA, and RNA editing modalities), RNA modifications and epigenetics (e.g., m6A regulation, non-canonical caps, and emerging RNA chemical biology), and enabling technologies for RNA delivery (including extracellular vesicles and engineered nanoparticle platforms). The program also emphasizes the interface of RNA technologies with immunology (mechanisms linking RNA and RNA modifications to antiviral/antitumor responses), the principles governing RNA cargo selection, transport, and processing across biological contexts, and RNA synthetic biology and AI-enabled design for programmable nucleic-acid systems. The meeting concludes with a focus on RNA diagnostics and biomarkers, including RNA-based liquid biopsy and clinically oriented detection platforms.
The conference chair is currently developing their preliminary program, which will include 9 sessions and the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by April 15, 2026. Please check back for updates.
